CURE had the privilege of attending the Hairy Cell Leukemia Foundation 2025 Conference in Bologna, Italy, where medical experts gathered to discuss advances in research, treatment ...
The gene p53 acts as a tumor suppressor and is often called the guardian of the genome. This gene is central to maintaining genomic stability, which prevents mutations from accumulating and leading to ...
"I really think this is a calling," said Allyson Letendre Petrone. "I don't think you go into oncology care and take care of ...
In contrast, the experts noted that several recent FDA approvals introduced first-in-class therapies to the oncology landscape. 1 Among these are menin inhibitors, which block the interaction between ...
The treatment of relapsed/refractory multiple myeloma dramatically changed in recent years with the emergence of therapies ...
The Independent Medical Alliance (IMA) announced today the addition of six distinguished senior fellows to its International Fellowship Program, bringing its senior fellow group to 54 leaders in the ...
The newly named ‘Chippewa Valley Cooperative Hospital’ is opening a new cancer center. 18 months ago, more than 300 cancer ...
The treatment landscape for high-risk myelodysplastic syndromes (HR MDS) is evolving, moving from supportive care toward a ...
Oncologist coverage across the US has declined in recent years, leading to care gaps, according to recently published research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback